Evolent Health (EVH) Long-Term Investments (2014 - 2026)

Evolent Health has reported Long-Term Investments for 13 years, with the latest figure at $8.8 million in Q2 2026.

• On a quarterly basis, Long-Term Investments fell 2.38% year-over-year to $8.8 million in Q2 2026; TTM through Jun 2026 was $8.8 million, a 2.38% decrease from a year earlier, with the FY2025 full-year figure at $9.0 million, down 40.22% from the prior year.
• Long-Term Investments was $8.8 million for Q2 2026 at Evolent Health, down from $9.0 million in the prior quarter.
• The five-year high for Long-Term Investments was $17.6 million in Q2 2023, with the low at $8.8 million in Q2 2026.
• Average Long-Term Investments over 5 years is $13.2 million, with a median of $13.0 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Long-Term Investments surged 35.47% in 2023, then tumbled 46.07% in 2025.
• Over 5 years, Long-Term Investments stood at $12.5 million in 2022, then jumped by 35.28% to $16.9 million in 2023, then retreated by 11.06% to $15.0 million in 2024, then tumbled by 40.22% to $9.0 million in 2025, then slipped by 2.25% to $8.8 million in 2026.
• The last three Long-Term Investments figures came in at $8.8 million (Q2 2026), $9.0 million (Q1 2026), and $9.0 million (Q4 2025), per Business Quant data.